| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002204 | American Journal of Ophthalmology | 2014 | 7 Pages |
Abstract
Travoprost with sofZia significantly lowers IOP throughout the diurnal and nocturnal periods, and increases ocular perfusion pressure in the diurnal, but not the nocturnal, period in open-angle glaucoma and ocular hypertension. The treatment effect on IOP endures for at least 84 hours after the last dose.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Leonard K. Seibold, Malik Y. Kahook,